Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.767683
Title: To design and develop semi-saturated and unsaturated bicyclic heterocycles for Fragment-Based Drug Discovery (FBDD) Campaigns
Author: Luise, Nicola
ISNI:       0000 0004 7660 6404
Awarding Body: University of Dundee
Current Institution: University of Dundee
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Restricted access.
Access from Institution:
Abstract:
The concept of Fragment-Based Drug-Discovery (FBDD) seeks to overcome current issues associated with High-Throughput Screening (HTS) for the identification of novel hits, which are ultimately elaborated into leads and drug candidates. This thesis focuses on the preparation of either novel or commercially limited fragments by engaging diverse synthetic strategies. Moreover, a fragment optimisation process is discussed. Chapter 2 details the generation of fully unsaturated and semi-saturated bicyclic heterocycles by adopting the concept of reagent- and scaffold-based Diversity-Oriented Synthesis (DOS). This approach was undertaken on three privileged heterocycles, armed with two key functionalities for the bicyclic construction. Chapter 3 discusses the application of diverse chemistry to construct bicyclic systems from a common intermediate, where pyrazole, a privileged heterocycle able to bind effectively to biological targets, is fused to diverse saturated counterparts. The synthesised fragments present an enhanced sp3-content that can deliver several physicochemical advantages. Chapter 4 follows the concept of increasing the sp3-portion within molecules that is introduced in chapter 3. However, the synthetic approach is different and based upon in continuous flow hydrogenation of fully unsaturated bicyclic heteroaromatics to deliver semi-saturated systems. The latter are further elaborated by using a simple toolkit of reactions in continuous flow. Chapter 5 describes the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), which is the sixth leading cause of mortality and it is estimated that 35 million of people are infected. A NMR fragment screen and following X-ray crystallography have identified diverse hits from which an isoquinolinone scaffold was chosen for optimisation. Driven by structural data, structure-activity relationship and supported by literature information, a weak fragment was optimised into a more potent binder of HIV-1 capsid.
Supervisor: Wyatt, Paul Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.767683  DOI: Not available
Share: